Navigation Links
COX-2 inhibitors Lessen Breast Cancer Risk

Selective usage of COX-2 inhibitors like rofecoxib (Vioxx) and celecoxib (Celebrex) reduces breast cancer risk by 71%, according to a study. The Ohio State University College of Medicine and Public Health's Randall Harris led the // research which came to this conclusion. The nonsteroidal anti-inflammatory drugs (NSAIDs) play a prominent role in the prevention of breast cancer.

The researchers observed that while daily use of selective COX-2 inhibitors was associated with a 71% reduction in the risk of breast cancer, non-selective COX-2 inhibitors, such as aspirin and ibuprofen, also reduced the risk of breast cancer. The study's results show that selective COX-2 inhibitors, as a group, were associated with a significantly reduced risk of breast cancer when taken daily for at least two years.

While a daily dose of 200 mg celecoxib reduced the risk of breast cancer by 83%, a daily dose of 25 mg rofecoxib reduced the risk of breast cancer by 64%. Regular use of non-selective COX-2 inhibitors like aspirin (325 mg), ibuprofen (200mg) and naproxen (250 mg) also significantly reduced the risk of breast cancer, but less so than the regular intake of selective COX-2 inhibitors. It was found that Ibuprofen and aspirin significantly decreased the risk of developing breast cancer when taken at least every other day for at least five years.

However, the researchers also found that regular intake of acetaminophen, an analgesic lacking COX-2 activity, had no effect on the risk of breast cancer. The study is published in the open access journal BMC Cancer.

Edited (ANI)
'"/>




Page: 1

Related medicine news :

1. Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer
2. Phase 3 trials of two multi-kinase inhibitors against cancer
3. Lessening operation and recovery time
4. Physical Exertion Can Lessen Depression
5. Risk Of Stroke Can Be Lessened By Proper Diet
6. Fatigue After Liver Transplantation Does Not Lessen With Time
7. Vulnerability to Ear Infections Lessened by Breast Feeding
8. A Discovery That may Lessen a Health Disparity
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: